Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer.
García-Vílchez R, Añazco-Guenkova AM, Dietmann S, López J, Morón-Calvente V, D'Ambrosi S, Nombela P, Zamacola K, Mendizabal I, García-Longarte S, Zabala-Letona A, Astobiza I, Fernández S, Paniagua A, Miguel-López B, Marchand V, Alonso-López D, Merkel A, García-Tuñón I, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Azkargorta M, Elortza F, Bárcena L, Gonzalez-Lopez M, Aransay AM, Di Domenico T, Sánchez-Martín MA, De Las Rivas J, Guil S, Motorin Y, Helm M, Pandolfi PP, Carracedo A, Blanco S. García-Vílchez R, et al. Among authors: unda m. Mol Cancer. 2023 Jul 29;22(1):119. doi: 10.1186/s12943-023-01809-8. Mol Cancer. 2023. PMID: 37516825 Free PMC article.
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: unda m. Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):392-393. doi: 10.1016/j.acuroe.2023.04.014. Epub 2023 Jun 8. Actas Urol Esp (Engl Ed). 2023. PMID: 37301369 English, Spanish. No abstract available.
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: unda m. Actas Urol Esp (Engl Ed). 2023 Mar;47(2):111-126. doi: 10.1016/j.acuroe.2022.12.004. Epub 2023 Jan 28. Actas Urol Esp (Engl Ed). 2023. PMID: 36720305 English, Spanish.
Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma.
Martín-Saiz L, Abad-García B, Solano-Iturri JD, Mosteiro L, Martín-Allende J, Rueda Y, Pérez-Fernández A, Unda M, Coterón-Ochoa P, Goya A, Saiz A, Martínez J, Ochoa B, Fresnedo O, Larrinaga G, Fernández JA. Martín-Saiz L, et al. Among authors: unda m. Anal Chem. 2023 Jan 31;95(4):2285-2293. doi: 10.1021/acs.analchem.2c03953. Epub 2023 Jan 13. Anal Chem. 2023. PMID: 36638042 Free PMC article.
Why is it necessary to produce a BCG strain in Spain?
Unda M, Cozar-Olmo JM, Alvarez-Osorio JL. Unda M, et al. Actas Urol Esp (Engl Ed). 2024 Apr 1:S2173-5786(24)00030-1. doi: 10.1016/j.acuroe.2024.04.003. Online ahead of print. Actas Urol Esp (Engl Ed). 2024. PMID: 38570032 English, Spanish. No abstract available.
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.
Angulo JC, Álvarez-Ossorio JL, Domínguez-Escrig JL, Moyano JL, Sousa A, Fernández JM, Gómez-Veiga F, Unda M, Carballido J, Carrero V, Fernandez-Aparicio T, García de Jalón Á, Solsona E, Inman B, Palou J. Angulo JC, et al. Among authors: unda m. Eur Urol Oncol. 2023 Feb;6(1):58-66. doi: 10.1016/j.euo.2022.10.008. Epub 2022 Nov 23. Eur Urol Oncol. 2023. PMID: 36435738 Clinical Trial.
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer.
Zabala-Letona A, Arruabarrena-Aristorena A, Fernandez-Ruiz S, Viera C, Carlevaris O, Ercilla A, Mendizabal I, Martin T, Macchia A, Camacho L, Pujana-Vaquerizo M, Sanchez-Mosquera P, Torrano V, Martin-Martin N, Zuniga-Garcia P, Castillo-Martin M, Ugalde-Olano A, Loizaga-Iriarte A, Unda M, Mato JM, Berra E, Martinez-Chantar ML, Carracedo A. Zabala-Letona A, et al. Among authors: unda m. Oncogenesis. 2022 Feb 23;11(1):10. doi: 10.1038/s41389-022-00382-x. Oncogenesis. 2022. PMID: 35197445 Free PMC article.
Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours.
Solano-Iturri JD, Echevarría E, Unda M, Loizaga-Iriarte A, Pérez-Fernández A, Angulo JC, López JI, Larrinaga G. Solano-Iturri JD, et al. Among authors: unda m. Diagnostics (Basel). 2021 Feb 10;11(2):272. doi: 10.3390/diagnostics11020272. Diagnostics (Basel). 2021. PMID: 33578778 Free PMC article.
Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Larrinaga G, Solano-Iturri JD, Errarte P, Unda M, Loizaga-Iriarte A, Pérez-Fernández A, Echevarría E, Asumendi A, Manini C, Angulo JC, López JI. Larrinaga G, et al. Among authors: unda m. Cancers (Basel). 2021 Feb 7;13(4):667. doi: 10.3390/cancers13040667. Cancers (Basel). 2021. PMID: 33562338 Free PMC article.
62 results